tiprankstipranks
IN8bio (INAB)
NASDAQ:INAB
Holding INAB?
Track your performance easily

IN8bio (INAB) Income Statement

175 Followers

IN8bio Income Statement

Last quarter (Q3 2024), IN8bio's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, IN8bio's net income was $-7.09M. See IN8bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
----$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 31.61M$ 30.34M$ 28.52M$ 14.65M$ 8.56M$ 5.07M
Operating Income
$ -31.45M$ -30.34M$ -28.52M$ -14.65M$ -8.56M$ -5.07M
Net Non Operating Interest Income Expense
$ 131.00K$ -138.00K$ -53.00K$ -86.00K-$ 0.00
Other Income Expense
-$ -330.00K---$ -68.00K
Pretax Income
$ -30.38M$ -30.01M$ -28.52M$ -14.65M$ -8.56M$ -5.13M
Tax Provision
-$ -6.08M$ -5.97M$ -4.61M--
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -31.45M$ -30.01M$ -28.52M$ -14.65M$ -10.34M$ -5.91M
Basic EPS
$ -0.77$ -1.00$ -1.36$ -1.47$ -0.91$ -0.83
Diluted EPS
$ -0.77$ -1.00$ -1.36$ -1.47$ -0.91$ -0.83
Basic Average Shares
$ 167.28M$ 29.86M$ 20.97M$ 9.97M$ 9.38M$ 6.17M
Diluted Average Shares
$ 167.28M$ 29.86M$ 20.97M-$ 9.38M$ 6.17M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 31.61M$ 30.34M$ 28.52M$ 14.65M$ 8.56M$ 5.07M
Net Income From Continuing And Discontinued Operation
$ -31.45M$ -30.01M$ -28.52M$ -14.65M$ -8.56M$ -5.13M
Normalized Income
$ -21.88M-$ -34.49M$ -19.26M$ -8.56M$ -5.07M
Interest Expense
-----$ 0.00
EBIT
$ -31.36M$ -35.95M$ -28.47M$ -14.57M$ -8.56M$ -5.07M
EBITDA
$ -28.76M$ -33.41M$ -27.41M$ -13.77M$ -8.47M$ -4.97M
Currency in USD

IN8bio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis